Singular Health Group Ltd (ASX: SHG) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Singular Health Group Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Singular Health Group Ltd (ASX: SHG)
Latest News
Healthcare Shares
This ASX biotech's shares are up strongly on good news out of the US
Ask a Fund Manager
2 small-cap ASX shares the market hasn't woken up to yet
Healthcare Shares
3 ASX health care shares that burned the market today
Share Gainers
These 3 ASX healthcare shares are soaring today. Why?
Share Market News
Why the Singular Health (ASX:SHG) share price opened nearly 10% higher today
Share Fallers
Why Fortescue, Freedom Foods, QBE, & Singular Health are sinking
Share Fallers
Why the Singular Health (ASX:SHG) share price is sinking 13% today
Share Market News
Why is the Singular Health (ASX:SHG) share price frozen?
Share Market News
The Singular Health (ASX:SHG) share price launched 27% higher today
Share Gainers
Why the Singular Health (ASX:SHG) share price is shooting 10% higher
Share Gainers
The Singular Health (ASX:SHG) share price is now up 140% since its IPO
Share Gainers
Singular Health (ASX:SHG) share price rockets 100% higher following IPO
SHG ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Singular Health Group Ltd
Singular Health Group Ltd provides medical software solutions. The company's business segment is the provision of Volume Rendering Platform (VRP) software, providing 3D printing services and 3D machine sales. It operates in one segment, which is the provision and development of medical technology within Australia.
SHG Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 06 Feb 2026 | $0.23 | $0.00 | 0.00% | 1,008,580 | $0.23 | $0.23 | $0.22 |
| 05 Feb 2026 | $0.23 | $-0.01 | -4.26% | 214,672 | $0.24 | $0.24 | $0.23 |
| 04 Feb 2026 | $0.24 | $0.00 | 0.00% | 126,925 | $0.24 | $0.24 | $0.23 |
| 03 Feb 2026 | $0.23 | $-0.01 | -4.08% | 984,402 | $0.25 | $0.25 | $0.23 |
| 02 Feb 2026 | $0.25 | $0.00 | 0.00% | 968,394 | $0.24 | $0.25 | $0.23 |
| 30 Jan 2026 | $0.25 | $0.01 | 4.26% | 372,806 | $0.24 | $0.25 | $0.24 |
| 29 Jan 2026 | $0.24 | $-0.02 | -8.00% | 880,573 | $0.25 | $0.25 | $0.23 |
| 28 Jan 2026 | $0.25 | $-0.01 | -3.85% | 335,070 | $0.26 | $0.26 | $0.24 |
| 27 Jan 2026 | $0.26 | $0.01 | 3.92% | 890,471 | $0.26 | $0.26 | $0.24 |
| 23 Jan 2026 | $0.26 | $0.01 | 4.00% | 179,103 | $0.25 | $0.26 | $0.25 |
| 22 Jan 2026 | $0.25 | $-0.01 | -3.92% | 599,317 | $0.26 | $0.26 | $0.25 |
| 21 Jan 2026 | $0.26 | $-0.01 | -3.85% | 1,156,095 | $0.26 | $0.26 | $0.25 |
| 20 Jan 2026 | $0.26 | $0.00 | 0.00% | 217,306 | $0.26 | $0.26 | $0.26 |
| 19 Jan 2026 | $0.26 | $0.00 | 0.00% | 201,745 | $0.27 | $0.27 | $0.26 |
| 16 Jan 2026 | $0.26 | $-0.02 | -7.27% | 84,150 | $0.27 | $0.27 | $0.26 |
| 15 Jan 2026 | $0.28 | $0.01 | 3.77% | 53,509 | $0.27 | $0.28 | $0.26 |
| 14 Jan 2026 | $0.27 | $0.00 | 0.00% | 365,619 | $0.27 | $0.27 | $0.26 |
| 13 Jan 2026 | $0.27 | $0.01 | 3.85% | 2,765,826 | $0.29 | $0.30 | $0.26 |
| 12 Jan 2026 | $0.26 | $0.01 | 4.00% | 231,070 | $0.25 | $0.26 | $0.25 |
| 09 Jan 2026 | $0.25 | $-0.02 | -7.41% | 922,848 | $0.27 | $0.27 | $0.25 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 18 Dec 2025 | Denning Chong | Issued | 6,000,000 | $1,500,000 |
Director remuneration.
|
| 25 Jul 2025 | Denning Chong | Buy | 302,962 | $100,000 |
On-market trade.
|
| 30 May 2025 | Denning Chong | Exercise | 2,000,000 | $600,000 |
Conversion of securities.
|
| 30 May 2025 | Denning Chong | Issued | 2,000,000 | $600,000 |
Conversion of securities.
|
| 15 Apr 2025 | Denning Chong | Issued | 10,000,000 | $2,200,000 |
Issue of options. As per announcement on 22/04/2025.
|
| 15 Apr 2025 | Andrew Just | Issued | 1,000,000 | $220,000 |
Director remuneration.
|
| 15 Apr 2025 | Howard Digby | Issued | 1,000,000 | $220,000 |
Director remuneration.
|
| 10 Feb 2025 | Denning Chong | Expiry | 4,500,000 | $1,080,000 |
Options expired.
|
| 10 Feb 2025 | Howard Digby | Expiry | 1,000,000 | $240,000 |
Options expired.
|
| 10 Feb 2025 | Andrew Just | Expiry | 1,000,000 | $240,000 |
Options expired.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Andrew Ian Just | Non-Executive Director | Jan 2021 |
Mr Just was formerly the Regional Director Asia Pacific for Radiometer, a Danaher Company and is currently CEO of Aeris Environmental. He has 30 years' global experience in delivering growth and scale competencies with Fortune 500 companies, including GE Healthcare, Danaher, Stryker, and Cochlear. Andrew has senior roles across business functions, with expertise in sales and marketing, performance management, commercial transactions, and operations in both turnaround and growth environments. He is also a Member of the Risk Committee.
|
| Mr Howard Andrew Digby | Non-Executive ChairmanNon-Executive Director | Jan 2021 |
Mr Digby began his career at IBM and has spent over 25 years managing technology-related businesses in the Asia Pacific region, of which 12 years were spent in Hong Kong. Prior to this he held senior management roles at Adobe and Gartner where his clients included semiconductor players inclusive of Samsung, Hynix and TSMC. Upon returning to Perth, Howard served as Executive Editor of WA Business News.
|
| Mr Denning Sang-Tatt Chong | Chief Executive OfficerManaging Director | Apr 2023 |
Mr Chong has been the principal of James Chong Lawyers since 2004 having experience in cross border transactions, and large commercial and corporate due diligence and acquisitions. Denning is also a director for the Australian subsidiaries of SGX listed Hiap Hoe Limited and a director of Aloft Hotel Perth. He is a member of the Risk committee.
|
| Mr Steven Douglas Wood | Company Secretary |
-
|
|
| Kyla Garic | Chief Financial Officer |
-
|
|
| Martina Mariano | Chief Operating officer |
-
|
|
| Steven Douglas Wood | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| JDE Capital Pty Ltd <JDE Capital A/C> (i) | 51,677,706 | 1.70% |
| Marin & Sons Strategies Llc | 13,564,934 | 4.46% |
| J P Morgan Nominees Australia Pty Limited | 10,783,463 | 3.54% |
| Manolev Superannuation Pty Ltd <Manolev Super Fund A/C> | 9,198,821 | 3.02% |
| Klosters Holdings Pty Ltd <Milbon Holdings A/C> | 8,150,000 | 2.68% |
| Ms Chong Ling Diamond Cheong | 7,065,754 | 2.32% |
| Marin And Sons Strategies Llc | 7,053,473 | 2.32% |
| Citicorp Nominees Pty Limited | 6,969,015 | 2.29% |
| JCC Health Pty Ltd <The JDE Medvr A/C> | 6,640,869 | 2.18% |
| Mr Ilia Manolev | 5,988,577 | 1.97% |
| Gaja Enterprises Ltd | 5,555,556 | 1.82% |
| HSBC Custody Nominees (Australia) Limited | 5,274,580 | 1.73% |
| Netwealth Investments Limited <Wrap Services A/C> | 5,031,661 | 1.65% |
| Three Bears Management Pty Ltd <Richardson Low Family A/C> (i) | 4,229,822 | 1.39% |
| JDE Capital Pty Ltd <JDE Capital A/C> (ii) | 3,500,000 | 1.15% |
| Three Bears Management Pty Ltd <Richardson Low Family A/C> (ii) | 3,375,000 | 1.11% |
| Mr Sim Tek Tan | 3,078,589 | 1.01% |
| Reenergise Australia Pty Ltd <Jrh Family A/C> | 3,077,000 | 1.01% |
| Ms Wei Zheng | 3,058,224 | 1.00% |
| Skyline Corporation Pty Ltd | 3,000,000 | 0.99% |
| Garry Tet Kheng Chong | 3,000,000 | 0.99% |